跳至主要内容
临床试验/NCT05699512
NCT05699512招募中不适用

What is the Prognosis of Functional Ability, Symptoms and Quality of Life in Patients That Are Treated in a University Hospital Because Symptoms of Post Covid-19 Condition

Helsinki University Central Hospital1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2021年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
1
主要终点
Change from baseline of WHODAS2.0 questionnaire as measured at 12 months

研究概览

简要总结

Up to 20% of patients with Covid-19 develop symptoms that last more than 3 months, which is known as long Covid or Post-Covid-19 condition. The mechanism of the long term symptoms is not totally understood although inflammation, autoimmune reactions and thromboembolism are among suspected contributors. At Helsinki University hospital, a long Covid clinic was opened in June 2021. The aim of this cohort study is to monitor the patients that attend the clinic, follow up their functional abilities, quality of life and prognosis.

详细描述

The patients are asked to give their informed consent for the participation in the cohort study. They fill in a questionnaire before entering the clinic that assesses their symptoms, previous medical history, medications, lifestyle, symptoms, sleep, psychosocial measures including depression, anxiety, resilience and quality of life.

The patients are asked to give blood samples that rule out other diseases that may cause the symptoms. At the clinic, they attend a physician's consultation with physical exam. Later, in another apppointment, a physicotherapist assesses their physicial functioning including 6 minutes walking test and grip strength. They also attend a psychologist who conducts short, 30 min neuro-cognitive testing.

Patients receive psychoeducation of the Post Covid-19 condition and individual, tailored support and rehabilitation. They are given the opportunity to take part in group counselling once a week during 6 weeks.

The patients are followed up by nurse telephone calls at 3, 6 and 12 months as well as by questionnaires via a secured website.

The main outcome measure in this study is functional ability as measured by WHODAS2.0.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a diagnosed Covid-19 infection at least 3 mo before entry (either PCR positive or antigen test positive or hospitalisation because of Covid-19)

排除标准

  • patients for whom participation would be too exhausting, for example bed patients
  • patients who cannot fill in the questionnaires in Finnish

结局指标

主要结局

Change from baseline of WHODAS2.0 questionnaire as measured at 12 months

时间窗: 0, 3, 6, and 12 months

Functional ability measured by WHODAS2.0 which is a measure developed by WHO and has 36 items. The minimum value is 0, the maximum value is 100. Higher score means worse functional ability.

次要结局

  • Sleep(0, 3, 6, and 12 months)
  • EUROHIS-8 Quality of life(0, 3, 6, and 12 months)
  • Depression(0, 3, 6, and 12 months)
  • Anxiety(0, 3, 6, and 12 months)
  • Health related quality of life(0, 3, 6, and 12 months)
  • Symptom severity(0, 3, 6, and 12 months)
  • Resilience(0, 3, 6, and 12 months)
  • SSD-12, somatic symptom disorder(0, 3, 6, and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Helena Liira

Chief Physician

Helsinki University Central Hospital

研究点 (1)

Loading locations...

相似试验